⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ASND News
Ascendis Pharma A/S American Depositary Shares
Ascendion Appraised at CMMI® Maturity Level 5 Reflecting Discipline Behind AI in Production
prnewswire.com
ASND
Stimvia impulsará la expansión global de su terapia insignia URIS® USA - español USA - Français
prnewswire.com
MDT
SYK
ASND
Stimvia erweitert den wissenschaftlichen Beirat und die kommerzielle Führung, um die globale Marktexpansion der Flaggschiff-Therapie URIS® voranzutreiben USA - Deutsch USA - español USA - English USA - English USA - Français
prnewswire.com
MDT
SYK
ASND
Laudio Wins “Health Administration Innovation Award” in 10th Annual MedTech Breakthrough Awards Program
globenewswire.com
ASND
Ascendis Pharma Reports First Quarter 2026 Financial Results
globenewswire.com
ASND
New 2-Year Data from Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) Show Pronounced Gains in Growth Outcomes in Children with Achondroplasia Aged ≥5 Years
globenewswire.com
ASND
Ascendis to Report First Quarter 2026 Financial Results and Provide Business Update on May 7, 2026
globenewswire.com
ASND
Hall Benefits Law Opens North Carolina and Ohio Offices and Welcomes Wendy Baker and Jeremy Sharp
prnewswire.com
CLF
FE
HNI
ASND
TRU
AYI
MMC
Inaugural Laudio-ASHHRA Report Reveals How HR Leaders Can Strengthen Workforce Stability Through Frontline Leadership
globenewswire.com
ASND
Ascendis Announces Redemption of All $575 Million of Outstanding 2.25% Convertible Senior Notes Due 2028
globenewswire.com
ASND